Correlation Between Mind Medicine and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mind Medicine and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mind Medicine and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mind Medicine and Spyre Therapeutics, you can compare the effects of market volatilities on Mind Medicine and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mind Medicine with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mind Medicine and Spyre Therapeutics.
Diversification Opportunities for Mind Medicine and Spyre Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mind and Spyre is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Mind Medicine and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Mind Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mind Medicine are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Mind Medicine i.e., Mind Medicine and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Mind Medicine and Spyre Therapeutics
Given the investment horizon of 90 days Mind Medicine is expected to generate 1.49 times more return on investment than Spyre Therapeutics. However, Mind Medicine is 1.49 times more volatile than Spyre Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 665.00 in Mind Medicine on August 28, 2024 and sell it today you would earn a total of 96.00 from holding Mind Medicine or generate 14.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Mind Medicine vs. Spyre Therapeutics
Performance |
| Timeline |
| Mind Medicine |
| Spyre Therapeutics |
Mind Medicine and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mind Medicine and Spyre Therapeutics
The main advantage of trading using opposite Mind Medicine and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mind Medicine position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Mind Medicine vs. Cybin Inc | Mind Medicine vs. Seelos Therapeutics | Mind Medicine vs. GH Research PLC | Mind Medicine vs. Awakn Life Sciences |
| Spyre Therapeutics vs. EastGroup Properties | Spyre Therapeutics vs. Doubledown Interactive Co | Spyre Therapeutics vs. NetEase | Spyre Therapeutics vs. Playstudios |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |